These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 17374527
1. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects. Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C. Cardiovasc Res; 2007 Jun 01; 74(3):537-45. PubMed ID: 17374527 [Abstract] [Full Text] [Related]
2. Exercise training reduces severity of atherosclerosis in apolipoprotein E knockout mice via nitric oxide. Shimada K, Kishimoto C, Okabe TA, Hattori M, Murayama T, Yokode M, Kita T. Circ J; 2007 Jul 01; 71(7):1147-51. PubMed ID: 17587726 [Abstract] [Full Text] [Related]
3. Atherosclerotic plaques induced by marble-burying behavior are stabilized by exercise training in experimental atherosclerosis. Shimada K, Mikami Y, Murayama T, Yokode M, Fujita M, Kita T, Kishimoto C. Int J Cardiol; 2011 Sep 15; 151(3):284-9. PubMed ID: 20579750 [Abstract] [Full Text] [Related]
4. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, Helm GA, Lusis AJ, Shi W. Life Sci; 2006 Jul 04; 79(6):525-31. PubMed ID: 16516241 [Abstract] [Full Text] [Related]
5. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. Arterioscler Thromb Vasc Biol; 2007 Dec 04; 27(12):2684-90. PubMed ID: 17916769 [Abstract] [Full Text] [Related]
6. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U. Circulation; 2008 May 06; 117(18):2377-87. PubMed ID: 18443241 [Abstract] [Full Text] [Related]
7. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. Jacob S, Laury-Kleintop L, Lanza-Jacoby S. J Surg Res; 2008 May 01; 146(1):135-42. PubMed ID: 17950326 [Abstract] [Full Text] [Related]
16. Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production. Shimada K, Murayama T, Yokode M, Kita T, Fujita M, Kishimoto C. Nutr Metab Cardiovasc Dis; 2011 Sep 06; 21(9):672-8. PubMed ID: 20399087 [Abstract] [Full Text] [Related]
17. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice. Xiao HB, Yang ZC, Jia SJ, Li NS, Jiang DJ, Zhang XH, Guo R, Zhou Z, Deng HW, Li YJ. Life Sci; 2007 Jun 13; 81(1):1-7. PubMed ID: 17532008 [Abstract] [Full Text] [Related]
18. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. Fabrizio Rodella L, Bonomini F, Rezzani R, Tengattini S, Hayek T, Aviram M, Keidar S, Coleman R, Bianchi R. Acta Histochem; 2007 Jun 13; 109(1):45-51. PubMed ID: 17046051 [Abstract] [Full Text] [Related]